Constellation Brands, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Business Segment Information (Tables)

Business Segment Information (Tables)

9 Months Ended

Nov. 30, 2024

Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows:


	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2024		2023		2024		2023
(in millions)
Cost of product sold
Settlements of undesignated commodity derivative contracts	$	23.8	$	8.5	$	8.3	$	2.3
Net gain (loss) on undesignated commodity derivative contracts	(10.5)		(28.9)		(0.8)		(13.3)
Flow through of inventory step-up	(7.6)		(2.7)		(5.2)		(1.2)






Comparable Adjustments, Cost of product sold	5.7		(23.1)		2.3		(12.2)

Selling, general, and administrative expenses
Restructuring and other strategic business development costs	(29.9)		(23.6)		(3.6)		(5.3)
Transition services agreements activity	(15.9)		(17.9)		(8.3)		(5.2)

Transaction, integration, and other acquisition-related costs	(0.9)		(0.6)		(0.1)		—

Other gains (losses) (1)	(19.8)		(9.3)		0.5		(0.2)
Comparable Adjustments, Selling, general, and administrative expenses	(66.5)		(51.4)		(11.5)		(10.7)

Goodwill impairment	(2,250.0)		—		—		—




Comparable Adjustments, Operating income (loss)	$	(2,310.8)	$	(74.5)	$	(9.2)	$	(22.9)


(1)	Primarily includes the following:
		For the Nine Months Ended November 30,				For the Three Months Ended November 30,
		2024		2023		2024		2023
	(in millions)
	Net loss on foreign currency as a result of the resolution of various tax examinations and assessments	$	(20.7)	$	—	$	—	$	—

	Gain (loss) on sale of business	$	—	$	(15.1)	$	—	$	(0.2)
	Recognition of a previously deferred gain upon release of a related indemnity	$	—	$	5.6	$	—	$	—

Segment information

Segment information is as follows:


	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2024		2023		2024		2023
(in millions)
Beer
Net sales	$	6,835.4	$	6,459.8	$	2,032.4	$	1,968.5





Segment operating income (loss)	$	2,770.6	$	2,509.0	$	769.9	$	757.3



Capital expenditures	$	758.3	$	704.4	$	186.7	$	264.1
Depreciation and amortization	$	262.3	$	242.2	$	93.4	$	82.0


	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2024		2023		2024		2023
(in millions)
Wine and Spirits
Net sales:
Wine	$	1,040.1	$	1,180.7	$	374.6	$	435.8
Spirits	169.0		182.1		56.8		66.6
Net sales	$	1,209.1	$	1,362.8	$	431.4	$	502.4





Segment operating income (loss)	$	225.4	$	287.6	$	95.2	$	127.6

Income (loss) from unconsolidated investments	$	31.4	$	38.1	$	25.6	$	27.5

Equity method investments	$	130.5	$	130.5	$	130.5	$	130.5

Capital expenditures	$	128.6	$	107.1	$	38.0	$	29.6
Depreciation and amortization	$	63.3	$	68.1	$	20.5	$	22.5

Corporate Operations and Other
Segment operating income (loss)	$	(180.0)	$	(181.8)	$	(62.9)	$	(65.1)
Income (loss) from unconsolidated investments	$	(5.5)	$	(62.7)	$	(1.7)	$	(8.3)

Equity method investments	$	20.5	$	102.8	$	20.5	$	102.8

Capital expenditures	$	44.6	$	100.4	$	3.7	$	36.2
Depreciation and amortization	$	15.2	$	12.5	$	5.4	$	3.9











Comparable Adjustments

Operating income (loss)	$	(2,310.8)	$	(74.5)	$	(9.2)	$	(22.9)
Income (loss) from unconsolidated investments	$	39.9	$	(452.8)	$	(38.9)	$	(61.0)


Consolidated
Net sales	$	8,044.5	$	7,822.6	$	2,463.8	$	2,470.9
Operating income (loss)	$	505.2	$	2,540.3	$	793.0	$	796.9
Income (loss) from unconsolidated investments (1)	$	65.8	$	(477.4)	$	(15.0)	$	(41.8)

Equity method investments	$	151.0	$	233.3	$	151.0	$	233.3

Capital expenditures	$	931.5	$	911.9	$	228.4	$	329.9
Depreciation and amortization	$	340.8	$	322.8	$	119.3	$	108.4


(1)	Income (loss) from unconsolidated investments consists of:
			For the Nine Months Ended November 30,				For the Three Months Ended November 30,
			2024		2023		2024		2023
		(in millions)
		Net gain (loss) in connection with Exchangeable Shares (i)	$	44.7	$	—	$	(38.6)	$	—
		Equity in earnings (losses) from other equity method investees and related activities	26.0		32.4		23.9		26.0
		Unrealized net gain (loss) on securities measured at fair value (i)	(2.5)		(85.4)		—		(11.0)
		Impairment of equity method investments	(2.4)		(136.1)		(0.3)		(0.3)
		Equity in earnings (losses) from Canopy and related activities	—		(288.3)		—		(56.5)


			$	65.8	$	(477.4)	$	(15.0)	$	(41.8)

(i)Effective as of May 31, 2023, we determined that the 2023 Canopy Promissory Note did not have future economic value given the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, prior to the

maturity of the note. Accordingly, the fair value of the remaining balance for this instrument was determined to be zero. In April 2024, we exchanged the 2023 Canopy Promissory Note for Exchangeable Shares. Additionally, as of November 30, 2024, we impaired our Exchangeable Shares.